project id: TCGA-UVM; case submitter id: TCGA-WC-AA9A; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.22; rna integrity number: 9.1; age at index: 70; days to birth: -25641; days to death: 453; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1941; year of death: 2012; age at diagnosis: 25641; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: Not Reported; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 959; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-WC-AA9A-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 97.0;